Thomas Calis

CEO Eurocept Pharmaceuticals | CEO Lucane Pharma | Chairman Dutch Committee on Orphan Drugs | Toezichthouder

Loosdrecht, North Holland, Netherlands

About

> Entrepreneurial leader with firm focus on international business development in pharmaceuticals Strategic brand / portfolio management Strategic Market Access / Regulatory solutions Sales Force Excellence & Execution Regulatory drug development Goal: happiness through healthy patient outcomes. Specialties: leading organizational change Value creation & capturing People development (Ultra) Rare Diseases

Experience

  • Eurocept (Ankeveen)
    • CEO
      Sep 2017 - Present · 8 yrs 10 mos

      Leading global business of Eurocept Pharmaceuticals & Lucane Pharma SAS

    • Directeur Pharmaceuticals Benelux
      Oct 2013 - Sep 2017 · 4 yrs

      Leading Eurocept pharmaceuticals, part of family owned fast growing Eurocept group specialized in pediatrics, anti infectives, anesthetics, urology, pain, oncology and home care solutions. General Management

  • CEO at Lucane Pharma
    Oct 2017 - Present · 8 yrs 9 mos

  • AstraZeneca (Zoetermeer, The Netherlands)
    • Head of Marketing & Market Access
      Oct 2012 - Sep 2013 · 1 yr

      Member of SMT, leading marketing team AstraZeneca BV in RITA, CV, Metabolics, CNS, Oncology, Infection, including market access, health care insurance policy, CME, digital and health care innovation.

    • Vice President Marketing & Sales
      2007 - Oct 2012 · 5 yrs 10 mos

      Leading CV / metabolic/ Respiratory / pain marketing & sales organization in primary care. Specific focus on: Strategic brand / portfolio management, Strategic Market Access, Sales Force Excellence Multi customer channel management

  • Sales Director at Novartis Nederland
    Aug 2005 - Dec 2006 · 1 yr 5 mos

    Head of Sales Primary Care GP + Hospital SF member of SMT

  • National Sales Manager at AstraZeneca
    Feb 2002 - Jul 2005 · 3 yrs 6 mos